"Atrium Medical Center is a full-service acute care hospital with a level III trauma center conveniently located off i-75 in Middletown. It is a member of Premier Health."

During the past decade, Atrium Medical Center-Middletown Regional Hospital conducted 134 clinical trials. In the 10-year time frame, 134 clinical trials started and 199 clinical trials were completed, i.e. on average, 148.5% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 74 clinical trials were completed. i.e. 129.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atrium Medical Center-Middletown Regional Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 141 trials, followed by "Alliance for Clinical Trials in Oncology" with 94 trials sponsored, "SWOG Cancer Research Network" with 83 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 25 trials sponsored and "Radiation Therapy Oncology Group" with 25 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atrium Medical Center-Middletown Regional Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 246 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator and "SWOG Cancer Research Network" with 12 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Atrium Medical Center-Middletown Regional Hospital" are "Breast Cancer" (39 trials), "Lymphoma" (21 trials), "Lung Cancer" (20 trials), "Colorectal Cancer" (13 trials) and "Recurrent Breast Carcinoma" (13 trials). Many other conditions were trialed in "Atrium Medical Center-Middletown Regional Hospital" in a lesser frequency.

Most popular intervention types in "Atrium Medical Center-Middletown Regional Hospital" are "Drug" (329 trials), "Other" (191 trials), "Biological" (153 trials), "Procedure" (81 trials) and "Radiation" (64 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (89 trials), "Quality-of-Life Assessment" (56 trials), "Carboplatin" (35 trials), "Paclitaxel" (35 trials) and "placebo" (32 trials). Other intervention names were less common.

The vast majority of trials in "Atrium Medical Center-Middletown Regional Hospital" are 319 trials for "All" genders, 62 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Atrium Medical Center-Middletown Regional Hospital". undefined are not yet recruiting, 56 are recruiting, 113 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 184 completed trials in Atrium Medical Center-Middletown Regional Hospital, 3 suspended trials, and 31 terminated clinical trials to date.

Out of the total trials that were conducted in Atrium Medical Center-Middletown Regional Hospital, 10 "Phase 1" clinical trials were conducted, 204 "Phase 2" clinical trials and 176 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".